Véronique Kemmel (Consuelo Sebastia Sancho)

Years Active: 2019-2021
Publications (10 Years): 4

This page only lists publications with an associated author ORCID identifier.

Publications

Amelia-Naomi Sabo, Sarah Jannier, Guillaume Becker, Jean-Marc Lessinger, Natacha Entz-Werlé, Véronique Kemmel
Sirolimus Pharmacokinetics Variability Points to the Relevance of Therapeutic Drug Monitoring in Pediatric Oncology. Pharmaceutics 13 (4) (2021)
Guillaume Becker, Sylvia Da Silva, Amelia-Naomi Sabo, Maria Cristina Antal, Véronique Kemmel, Laurent Monassier
Blood-Brain Barrier Permeability: Is 5-Hydroxytryptamine Receptor Type 4 a Game Changer? Pharmaceutics 13 (11) (2021)
Sarah Jannier, Véronique Kemmel, Véronique Kemmel, Agathe Chammas, Amelia-Naomie Sabo, Erwan Pencreach, Françoise Farace, Marie Pierre Chenard, Benoit Lhermitte, Birgit Geoerger, Isabelle Aerts, Didier Frappaz, Pierre Leblond, Nicolas André, Stephane Ducassou, Nadège Corradini, Anne Isabelle Bertozzi, Eric Guérin, Florence Vincent, Michel Velten, Natacha Entz-Werle
SFCE-RAPIRI Phase I Study of Rapamycin Plus Irinotecan: A New Way to Target Intra-Tumor Hypoxia in Pediatric Refractory Cancers. Cancers 12 (10) (2020)
Charlotte Nazon, Amelia-Naomi Sabo, Guillaume Becker, Jean-Marc Lessinger, Véronique Kemmel, Catherine Paillard
Optimizing Hydroxyurea Treatment for Sickle Cell Disease Patients: The Pharmacokinetic Approach. Journal of clinical medicine 8 (10) (2019)

Véronique Kemmel.css-eqlu8i{font-size:small;padding-left:4px;} (Consuelo Sebastia Sancho)